MoneyWorks4Me

Eiko Lifesciences informs about disclosure

04 Mar 2025 Evaluate
Eiko Lifesciences has informed about disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhant Kabra.

The above information is a part of company’s filings submitted to BSE.

Eiko Lifesciences Share Price

48.14 -1.62 (-3.26%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2609.10
BASF India 4083.85
Pidilite Inds. 1690.00
Tata Chemicals 670.40
GNFC 568.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: